Medindia LOGIN REGISTER
Medindia

Asparaginase / Crisantaspase Interaction with other Drugs


Asparaginase / Crisantaspase is an antineoplastic agent, prescribed for lymphocytic leukemia either alone or with other medications.

Asparaginase / Crisantaspase Interaction with 18 drugs. Find out more in the list below:

Acetyldigitoxin


Acetyldigitoxin may decrease the cardiotoxic activities of Asparaginase Escherichia coli.

Ancestim


The risk or severity of cytotoxicity can be increased when Ancestim is combined with Asparaginase Escherichia coli.

Bevacizumab


Bevacizumab may increase the cardiotoxic activities of Asparaginase Escherichia coli.

Advertisement

Bevacizumab-Awwb


Bevacizumab may increase the cardiotoxic activities of Asparaginase Escherichia coli.

Cabazitaxel


The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Asparaginase Escherichia coli.

Cyclophosphamide


Cyclophosphamide may increase the cardiotoxic activities of Asparaginase Escherichia coli.

Advertisement

Cyclophosphamide Anhydrous


Cyclophosphamide may increase the cardiotoxic activities of Asparaginase Escherichia coli.

Deslanoside


Deslanoside may decrease the cardiotoxic activities of Asparaginase Escherichia coli.

Dexamethasone


The serum concentration of Dexamethasone can be increased when it is combined with Asparaginase Escherichia coli.

Advertisement

Digitoxin


Digitoxin may decrease the cardiotoxic activities of Asparaginase Escherichia coli.

Digoxin


Digoxin may decrease the cardiotoxic activities of Asparaginase Escherichia coli.

Docetaxel


The risk or severity of adverse effects can be increased when Docetaxel is combined with Asparaginase Escherichia coli.

DOCETAXEL ANHYDROUS


The risk or severity of adverse effects can be increased when Docetaxel is combined with Asparaginase Escherichia coli.

Ouabain


Ouabain may decrease the cardiotoxic activities of Asparaginase Escherichia coli.

Ovine Digoxin Immune Fab


Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Asparaginase Escherichia coli.

Paclitaxel


The risk or severity of adverse effects can be increased when Paclitaxel is combined with Asparaginase Escherichia coli.

Proscillaridin


Proscillaridin may decrease the cardiotoxic activities of Asparaginase Escherichia coli.

Trastuzumab


Trastuzumab may increase the cardiotoxic activities of Asparaginase Escherichia coli.

Advertisement
Drugs A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Get Health and Wellness Secrets from Our Engaging eBooks
Stay Connected
Available on the Android Market Available on the App Store